Sedation for Cardioversio
Phase 3
- Conditions
- Sedation for Cardioversion.
- Registration Number
- IRCT201202269147N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Age over 18 years; symptomatic Tachydysrythmia
Exclusion criteria: Drug sensitivity; pneumothorax; small bowel obstruction; chronic obstructive pulmonary disease; head trauma with decreased level of consciousness; Maxiofacial Injury; air emboli; inner ear infection
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Pain. Timepoint: After Sedation. Method of measurement: Visual Analogue Scale.;Sedation Level. Timepoint: During Sedation. Method of measurement: Richmond analgesia and sedation Scale.
- Secondary Outcome Measures
Name Time Method Respiratory arrest. Timepoint: During sedation. Method of measurement: Patient Respiration observe.;More Doses. Timepoint: During sedation. Method of measurement: More than primery standard dose.;Time of Sedation. Timepoint: From onset of sedation untill return to primery level of consiousness. Method of measurement: Minutes.